demonstrated that large opioid requirement and high expression of the MOR were associated with shorter progression-free survival and OS in patients with metastatic prostate cancer 17,18 To complicate the matter, the association between the intraoperative administration of sufentanil and higher rate of recurrence after breast cancer surgery was not significant 19. This evidence concerns the gene OPRM1 and metastatic prostate carcinoma.